Preclinical studies have demonstrated that GLP-1 receptors are expressed in various ocular tissues, including the retina, and may play roles in neuroprotection, inflammation modulation, and vascular regulation
The injection is administered subcutaneously (just under the skin) on the same day each weekat any time of day, with or without food
When injected, it works by breaking down the walls of fat cells in the treatment area, allowing the body to gradually eliminate the fat through its natural processes
This is absolutely essential for research protocols that require drawing multiple doses from the same vial over a period of weeks
F., Lingvay, I., & Lau, D
(average results) Wegovy (semaglutide) GLP-1 only In the STEP-1 study (68 weeks), average weight change was about: 14.9% with Wegovy 2.4% with placebo (dummy injection) What that looks like: If you start at 100 kg , 14.9% is about 15 kg lost on average